Reinfection with SARS-CoV-2: Implications for Vaccines

  title={Reinfection with SARS-CoV-2: Implications for Vaccines},
  author={J. Cohen and P. Burbelo},
  journal={Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America},
  • J. Cohen, P. Burbelo
  • Published 2020
  • Medicine
  • Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
  • Abstract Infection with SARS-CoV-2 has become pandemic and the duration of protective immunity to the virus is unknown. Cases of persons reinfected with the virus are being reported with increasing frequency. At present it is unclear how common reinfection with SARS-CoV-2 is and how long serum antibodies and virus-specific T cells persist after infection. For many other respiratory virus infections, including influenza and the seasonal coronaviruses that cause colds, serum antibodies persist… CONTINUE READING
    5 Citations

    Tables from this paper


    Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
    • 129
    • PDF
    Antibodies to SARS-CoV-2 are associated with protection against reinfection
    • 18
    • PDF
    Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
    • 30
    Humoral Immune Response to SARS-CoV-2 in Iceland
    • 212
    Correlates of protection against SARS-CoV-2 in rhesus macaques.
    • 34
    • PDF
    Immunity to and frequency of reinfection with respiratory syncytial virus.
    • 602
    Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.
    • 16
    COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing
    • K. To, I. F. Hung, +17 authors K. Yuen
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2020
    • 184